| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.956 | 0.004 | 0.968 | Analgesic | 0.941 0.004 DBMET03206 0.968 0.004 DBMET03208 0.884 0.005 DBMET03207 | DBMET03208 | |
| 0.764 | 0.002 | 0.798 | Opioid mu receptor agonist | 0.711 0.002 DBMET03206 0.798 0.001 DBMET03208 0.63 0.003 DBMET03207 | DBMET03208 | |
| 0.738 | 0.002 | 0.776 | Opioid agonist | 0.682 0.003 DBMET03206 0.776 0.002 DBMET03208 0.533 0.004 DBMET03207 | DBMET03208 | |
| 0.539 | 0.003 | 0.539 | Nav1.5 sodium channel blocker | 0.422 0.004 DBMET03206 0.356 0.004 DBMET03208 0.189 0.015 DBMET03207 | ||
| 0.375 | 0.031 | 0.441 | Potassium channel (Voltage-sensitive) blocker | 0.262 0.062 DBMET03206 0.441 0.021 DBMET03208 | DBMET03208 | |
| 0.367 | 0.034 | 0.473 | HERG channel blocker | 0.24 0.07 DBMET03206 0.473 0.018 DBMET03208 | DBMET03208 | |
| 0.327 | 0.005 | 0.537 | Opioid antagonist | 0.255 0.008 DBMET03206 0.537 0.004 DBMET03208 0.185 0.017 DBMET03207 | DBMET03208 | |
| 0.322 | 0.005 | 0.524 | Opioid mu receptor antagonist | 0.245 0.005 DBMET03206 0.524 0.004 DBMET03208 0.175 0.013 DBMET03207 | DBMET03208 | |
| 0.303 | 0.005 | 0.374 | Analgesic, opioid | 0.23 0.008 DBMET03206 0.374 0.005 DBMET03208 0.15 0.015 DBMET03207 | DBMET03208 | |
| 0.28 | 0.053 | 0.28 | Potassium channel blocker | 0.191 0.098 DBMET03206 0.263 0.06 DBMET03208 | ||
| 0.257 | 0.031 | 0.375 | Lipocortins synthesis antagonist | 0.284 0.024 DBMET03206 0.375 0.011 DBMET03208 0.233 0.039 DBMET03207 | DBMET03208 | |
| 0.21 | 0.026 | 0.21 | Sodium channel (voltage-gated) blocker | 0.141 0.061 DBMET03206 0.166 0.044 DBMET03208 | ||
| 0.172 | 0.013 | 0.179 | Opioid kappa receptor antagonist | 0.133 0.02 DBMET03206 0.179 0.012 DBMET03208 0.084 0.053 DBMET03207 | DBMET03208 | |
| 0.133 | 0.007 | 0.133 | Opioid kappa receptor agonist | 0.111 0.008 DBMET03206 0.116 0.008 DBMET03208 0.063 0.017 DBMET03207 | ||
| 0.169 | 0.045 | 0.169 | Sodium channel blocker | 0.106 0.104 DBMET03206 0.131 0.073 DBMET03208 | ||
| 0.124 | 0.012 | 0.213 | Bombesin 1 receptor agonist | 0.092 0.02 DBMET03206 0.213 0.004 DBMET03208 0.061 0.04 DBMET03207 | DBMET03208 | |
| 0.257 | 0.15 | 0.324 | Antiobesity | 0.288 0.125 DBMET03206 0.275 0.135 DBMET03208 0.324 0.101 DBMET03207 | DBMET03207 | |
| 0.097 | 0.054 | 0.097 | Alpha 2d adrenoreceptor antagonist | |||
| 0.135 | 0.102 | 0.135 | Polo-like kinase-3 inhibitor | |||
| 0.063 | 0.044 | 0.074 | Opioid delta receptor antagonist | 0.074 0.038 DBMET03208 | DBMET03208 | |
| 0.038 | 0.021 | 0.04 | Opioid delta receptor agonist | 0.033 0.028 DBMET03206 0.04 0.02 DBMET03208 | DBMET03208 | |
| 0.036 | 0.026 | 0.058 | Bombesin 1 receptor antagonist | 0.058 0.009 DBMET03208 | DBMET03208 | |
| 0.035 | 0.038 | 0.04 | Vanilloid 3 antagonist | 0.04 0.023 DBMET03206 | DBMET03206 | |
| 0.013 | 0.031 | 0.037 | Epoxide hydrolase 2 inhibitor | 0.037 0.01 DBMET03208 | DBMET03208 | |
| 0.058 | 0.092 | 0.072 | Phosphodiesterase VIII inhibitor | 0.072 0.048 DBMET03208 | DBMET03208 | |
| 0.034 | 0.071 | 0.047 | Bombesin antagonist | 0.047 0.034 DBMET03208 | DBMET03208 | |
| 0.116 | 0.179 | 0.262 | Non-steroidal antiinflammatory agent | 0.262 0.038 DBMET03207 | DBMET03207 | |
| 0.009 | 0.077 | 0.033 | Glycine transporter 1 inhibitor | 0.033 0.025 DBMET03208 | DBMET03208 | |
| 0.033 | 0.105 | 0.061 | Glucose-6-phosphate translocase inhibitor | 0.061 0.023 DBMET03207 | DBMET03207 | |
| 0.04 | 0.138 | 0.093 | CYP2A6 inhibitor | 0.093 0.039 DBMET03208 | DBMET03208 | |
| 0.014 | 0.152 | 0.043 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.043 0.037 DBMET03208 | DBMET03208 | |
| 0.136 | 0.277 | 0.381 | Immunosuppressant | 0.237 0.159 DBMET03206 0.381 0.071 DBMET03207 | DBMET03207 | |
| 0.016 | 0.23 | 0.077 | Protein 50S ribosomal subunit inhibitor | 0.077 0.021 DBMET03207 | DBMET03207 | |
| 0.085 | 0.333 | 0.376 | Hypoglycemic | 0.376 0.032 DBMET03207 | DBMET03207 | |
| 0.024 | 0.282 | 0.043 | Parathyroid hormone antagonist | 0.043 0.036 DBMET03208 | DBMET03208 | |
| 0.065 | 0.329 | 0.149 | Insulin secretagoues | 0.149 0.075 DBMET03207 | DBMET03207 | |
| 0.028 | 0.292 | 0.099 | Protein kinase C delta inhibitor | 0.099 0.053 DBMET03208 | DBMET03208 | |
| 0.057 | 0.329 | 0.229 | Nitric oxide antagonist | 0.229 0.058 DBMET03207 | DBMET03207 | |
| 0.046 | 0.325 | 0.093 | Toll-Like receptor 3 antagonist | 0.093 0.063 DBMET03208 | DBMET03208 | |
| 0.127 | 0.409 | 0.557 | Cyclophilin D inhibitor | 0.256 0.206 DBMET03206 0.276 0.185 DBMET03208 0.557 0.036 DBMET03207 | DBMET03207 | |
| 0.032 | 0.392 | 0.131 | Beta amyloid protein antagonist | 0.131 0.056 DBMET03208 | DBMET03208 | |
| 0.006 | 0.376 | 0.096 | Antineoplastic antibiotic | 0.096 0.048 DBMET03207 | DBMET03207 | |
| 0.105 | 0.507 | 0.247 | 5 Hydroxytryptamine 3E antagonist | 0.247 0.017 DBMET03208 | DBMET03208 | |
| 0.015 | 0.422 | 0.068 | 5 Hydroxytryptamine 1B agonist | 0.068 0.019 DBMET03208 | DBMET03208 | |
| 0.056 | 0.479 | 0.181 | Superoxide dismutase inhibitor | 0.181 0.14 DBMET03208 | DBMET03208 | |
| 0.008 | 0.433 | 0.054 | Histamine agonist | 0.054 0.035 DBMET03208 | DBMET03208 | |
| 0.038 | 0.471 | 0.202 | Platelet adhesion inhibitor | 0.202 0.07 DBMET03207 | DBMET03207 | |
| 0.061 | 0.496 | 0.153 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.153 0.143 DBMET03208 | DBMET03208 | |
| 0.081 | 0.524 | 0.123 | CC chemokine 6 receptor antagonist | 0.123 0.1 DBMET03207 | DBMET03207 | |
| 0.03 | 0.475 | 0.128 | Lanosterol 14 alpha demethylase inhibitor | 0.128 0.024 DBMET03208 | DBMET03208 | |
| 0.033 | 0.504 | 0.085 | Transcription factor NF kappa B stimulant | 0.085 0.058 DBMET03207 | DBMET03207 | |
| 0.071 | 0.545 | 0.232 | Caspase 3 stimulant | 0.232 0.129 DBMET03207 | DBMET03207 | |
| 0.006 | 0.482 | 0.041 | Histamine H1 receptor agonist | 0.041 0.037 DBMET03208 | DBMET03208 | |
| 0.012 | 0.504 | 0.052 | Antibiotic Aminoglycoside-like | 0.052 0.012 DBMET03207 | DBMET03207 | |
| 0.083 | 0.592 | 0.252 | Caspase 9 stimulant | 0.252 0.251 DBMET03208 | DBMET03208 | |
| 0.006 | 0.516 | 0.068 | Na+ K+ transporting ATPase inhibitor | 0.068 0.062 DBMET03208 | DBMET03208 | |
| 0.059 | 0.571 | 0.202 | Sodium/bile acid cotransporter inhibitor | 0.202 0.185 DBMET03206 | DBMET03206 | |
| 0.02 | 0.559 | 0.37 | Angiogenesis stimulant | 0.37 0.028 DBMET03207 | DBMET03207 | |
| 0.03 | 0.579 | 0.123 | Adenylate cyclase stimulant | 0.123 0.118 DBMET03208 | DBMET03208 | |
| 0.024 | 0.609 | 0.327 | Transcription factor NF kappa B inhibitor | 0.327 0.084 DBMET03207 | DBMET03207 | |
| 0.032 | 0.631 | 0.157 | Neurotrophic factor enhancer | 0.157 0.128 DBMET03208 | DBMET03208 | |
| 0.006 | 0.623 | 0.073 | Porphobilinogen synthase inhibitor | 0.073 0.053 DBMET03208 | DBMET03208 | |
| 0.011 | 0.63 | 0.125 | Histamine N-methyltransferase inhibitor | 0.125 0.026 DBMET03208 | DBMET03208 | |
| 0.019 | 0.65 | 0.14 | Hemostatic | 0.14 0.081 DBMET03207 | DBMET03207 | |
| 0.006 | 0.639 | 0.083 | Phenylalanine 4-hydroxylase inhibitor | 0.083 0.035 DBMET03208 | DBMET03208 | |
| 0.051 | 0.684 | 0.285 | 5 Hydroxytryptamine release stimulant | 0.285 0.075 DBMET03208 | DBMET03208 | |
| 0.031 | 0.68 | 0.219 | Hepatoprotectant | 0.219 0.055 DBMET03207 | DBMET03207 | |
| 0.021 | 0.68 | 0.228 | Tumour necrosis factor alpha release inhibitor | 0.228 0.087 DBMET03207 | DBMET03207 | |
| 0.011 | 0.685 | 0.097 | GABA C receptor rho-1 antagonist | 0.097 0.067 DBMET03208 | DBMET03208 | |
| 0.009 | 0.689 | 0.094 | GABA C receptor agonist | 0.094 0.073 DBMET03208 | DBMET03208 | |
| 0.038 | 0.73 | 0.479 | Antiinflammatory | 0.479 0.097 DBMET03207 | DBMET03207 | |
| 0.008 | 0.723 | 0.12 | GABA C receptor antagonist | 0.12 0.053 DBMET03208 | DBMET03208 | |
| 0.017 | 0.733 | 0.221 | Antithrombotic | 0.221 0.153 DBMET03207 | DBMET03207 | |
| 0.004 | 0.722 | 0.155 | Selectin antagonist | 0.155 0.017 DBMET03207 | DBMET03207 | |
| 0.015 | 0.758 | 0.437 | Antibacterial | 0.437 0.061 DBMET03207 | DBMET03207 | |
| 0.06 | 0.812 | 0.299 | Peptidyltransferase inhibitor | 0.299 0.025 DBMET03207 | DBMET03207 | |
| 0.008 | 0.761 | 0.188 | Free radical scavenger | 0.188 0.108 DBMET03207 | DBMET03207 | |
| 0.032 | 0.79 | 0.23 | Apoptosis antagonist | 0.23 0.147 DBMET03207 | DBMET03207 | |
| 0.007 | 0.797 | 0.242 | Antioxidant | 0.242 0.088 DBMET03207 | DBMET03207 | |
| 0.011 | 0.881 | 0.286 | Apoptosis agonist | 0.286 0.182 DBMET03207 | DBMET03207 | |
| 0.034 | 0.938 | 0.247 | Interleukin 2 agonist | 0.247 0.121 DBMET03207 | DBMET03207 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |